1. Gao L, Wang W, Meng X, et al. TPA: Two‐stage progressive attention segmentation framework for hepatocellular carcinoma on multi‐modality MRI. Medical Physics. Published online February 2, 2024:mp.16968. doi:10.1002/mp.16968 (通讯作者) 

2. Zhou S, Wang S, Xiang J, et al.Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta‑analysis. Abdom Radiol. Published online January 10, 2024. doi:10.1007/s00261-023-04143-1(通讯作者) 

3. Cui Y, Zhang S, Wang W, et al.  Effects of Low-Osmolar Contrast Media on Long-Term Renal Impairment After Coronary Angiography: Iohexol Versus Iopromide. American Journal of Cardiology. 2024;211:209-218. doi:10.1016/j.amjcard.2023.11.029 (通讯作者)

4. Wang, YC., Zhang, SH., Lv, WH. _et al._ Added value of chest CT images to a personalized prognostic model in acute respiratory distress syndrome: a retrospective study. Chin J Acad Radiol. 2023,6:47-56 (第一作者)

5. Wang Y, Luo H, Liu S, Hao T, Mortimer K, Yang Y, et al. Respiratory failure among patients with COVID-19 in Jiangsu province, China: a multicentre retrospective cohort study. Epidemiology and Infection. 2021;2021149:e31.(共同一作)

6. Luo H, Wang Y, Liu S, Chen R, Chen T, Yang Y, et al. Associations between CT pulmonary opacity score on admission and clinical characteristics and outcomes in patients with COVID-19. Internal and Emergency Medicine. 2021;Jun 30;1-11.(共同一作)

7. Wang Y , Luo H, Liu S, Huang S, Zhou Z, Yu Q, et al. Dynamic evolution of COVID-19 on chest computed tomography: experience from Jiangsu Province of China. Eur Radiol. 2020;30:6194-203(第一作者)

8. Yu Q, Wang Y, Huang S, Liu S, Zhou Z, Zhang S, et al. Multicenter cohort study demonstrates more consolidation in upper lungs on initial CT increases the risk of adverse clinical outcome in COVID-19 patients. Theranostics. 2020;10(12):5641-8.(共同一作)

9. Meng XP, Wang YC, Ju S, Lu CQ, Zhong BY, Ni CF, et al. Radiomics Analysis on Multiphase Contrast-Enhanced CT: A Survival Prediction Tool in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Front Oncol. 2020;10(July):1-12.(共同一作)

10. Liu S, Luo H, Wang Y, Cuevas LE, Wang D, Ju S, et al. Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study. BMC Infect Dis. 2020;20(1):584.(共同一作)

11. Wang YC, Chang D, Zhang SJ, Wang Q, Ju S. The Accuracy of Renal Function Measurements in Obstructive Hydronephrosis Using Dynamic Contrast-Enhanced MR Renography. Am J Roentgenol. 2019. 213(4):859–66.(第一作者)

12. Yan X, Shao R, Wang YC, Mao X, Lei J, Zhang L, et al. Functional magnetic resonance imaging-based assessment of terlipressin vs. octreotide on renal function in cirrhotic patients with acute variceal bleeding (CHESS1903): study protocol of a multicenter randomized controlled trial. Ann Transl Med. 2019;7(20):586–586.(共同一作)

13. Wang YC, Feng Y, Lu CQ, Ju S. Renal fat fraction and diffusion tensor imaging in patients with early-stage diabetic nephropathy. Eur Radiol. 2018. 2018.28(8):3326-34(第一作者)

14. Gao X, Wang YC, Liu Y, Yue Q, Liu Z, Ke M, et al. Nanoagonist-mediated endothelial tight junction opening: A strategy for safely increasing brain drug delivery in mice. J Cereb Blood Flow Metab. 2017;37(4):1410–24. (共同一作)

15. Wang YC, Tang A, Chang D, Lu CQ, Zhang SJ, Ju S. Long-Term Adverse Effects of Low-Osmolar Compared With Iso-Osmolar Contrast Media After Coronary Angiography. Am J Cardiol. 2016;118(7):985–90. (第一作者)

16. Wang YC, Tang A, Chang D, Zhang SJ, Ju S. Significant Perturbation in Renal Functional Magnetic Resonance Imaging Parameters and Contrast Retention for Iodixanol Compared With Iopromide. Invest Radiol. 2014;49(11):699–706.  (第一作者)